
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Exchanges
00:00
Breakthrough in Weight Loss Treatments
This chapter discusses the efficacy and safety of newer weight loss drugs, highlighting their ability to achieve 15-20% weight loss. It delves into the potential for wider adoption of anti-obesity drugs and the estimated $100 billion market for these drugs by 2030. The chapter also addresses the cost and insurance coverage of prescription anti-obesity drugs, as well as the long-term effectiveness and challenges of maintaining weight loss.
Transcript
Play full episode